New perspectives in cardiovascular risk reduction: focus on HDL

Submitted: November 25, 2015
Accepted: November 25, 2015
Published: November 25, 2015
Abstract Views: 1062
PDF: 632
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide, mostly contributing to hospitalizations and health care costs. Dyslipidemias represent one of the major cardiovascular risk factor and its management, throughout life-style modifications and pharmacological interventions, has shown to reduce cardiac events. The risk of adverse cardiovascular events is related not only to elevated LDL blood levels, but also to decreased HDL concentrations, that exhibit protective effects in the development of atherosclerotic process. Aim of this review is to summarize current evidences about defensing effects of such lipoproteins and to show the most recent pharmacological strategies to reduce cardiovascular risk through the increase of their circulating levels.



PlumX Metrics


Download data is not yet available.


How to Cite

Paolillo, Stefania, Giuseppe Luca Della Ratta, Alice Vitagliano, Annapaola Cirillo, Elisabetta Lardino, Tiziana Formisano, Irma Fabiani, Angela Maria Pellegrino, Pietro Riello, and Pasquale Perrone Filardi. 2015. “New Perspectives in Cardiovascular Risk Reduction: Focus on HDL”. Monaldi Archives for Chest Disease 80 (1).